Entecavir demonstrates consistent responses among baseline subgroups in the treatment of nucleoside-naive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B | AVESİS

Bezmialem Vakıf University Research Information System

Entecavir demonstrates consistent responses among baseline subgroups in the treatment of nucleoside-naive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B

Copy For Citation

Brown R., Lok A., Gish R., Schiff E., Shouval D., Senturk H., ...More

Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Illinois, United States Of America, 14 - 19 May 2005, vol.128

Publication Type: Conference Paper / Summary Text
Volume: 128
City: Illinois
Country: United States Of America
Bezmialem Vakıf University Affiliated: Yes